HEALTHSTORY 603· AUGUST 2, 2026

Trump administration shifts 340B drug program from upfront discounts to rebates, drawing hospital backlash

A federal law requires pharmaceutical manufacturers to sell discounted medicines to specific hospitals and clinics. That discount mechanism, the foundation of the 340B Drug Pricing Program, is now being reshaped. The Trump administration…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 602Amazon to return $600 million in tariff refunds to some customers after Supreme Court ruling NEXT STORY 604 →Iran warns of retaliation if the United States follows through on attack threats

Keep reading

More from the desk.

16HEALTH

Pennsylvania records fourth measles death, an 18-year-old from Mifflin County

Pennsylvania has now reported a fourth death connected to measles. The latest was an 18-year-old resident of Mifflin County, in the center of the state, who died from acute disseminated encephalomyelitis, a rare and severe neurological…

health1 MIN

28HEALTH

Novartis shares drop 11% on drug failure as biosimilar gap threatens $200 billion in savings

A failed clinical trial wiped nearly $30 billion from Novartis's market value this week after shares fell 11% in a single session, erasing all the gains the stock had made since the start of the year. The drug that failed, del-desiran, was…

health2 MIN

36HEALTH

EU legal adviser hands pharma a win on wastewater costs

Pharmaceutical and cosmetics companies across Europe may be off the hook for the largest share of a continent-wide water cleanup effort, after a legal adviser to the EU's top court recommended striki

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk